Covered recipient · General Payments record
WAFA AKKAD
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,178.00
- Reported across 242 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $391.25 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $161.59 | 20 |
| Astellas Pharma US Inc | $54.54 | 2 |
| Lilly USA, LLC | $35.12 | 2 |
| GlaxoSmithKline, LLC. | $31.95 | 2 |
| Acerta Pharma LLC | $27.59 | 2 |
| Exact Sciences Corporation | $23.33 | 1 |
| Radius Health, Inc. | $20.79 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.30 | 1 |
| Novo Nordisk AS | $18.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.95 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191656 | CMS |
| ABBVIE INC. | $4.63 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191658 | CMS |
| ABBVIE INC. | $22.00 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191660 | CMS |
| ABBVIE INC. | $6.95 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191662 | CMS |
| ABBVIE INC. | $12.62 | 02/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191664 | CMS |
| ABBVIE INC. | $9.32 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191666 | CMS |
| ABBVIE INC. | $6.12 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191668 | CMS |
| ABBVIE INC. | $10.24 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191670 | CMS |
| ABBVIE INC. | $6.66 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191672 | CMS |
| ABBVIE INC. | $13.22 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191674 | CMS |
| ABBVIE INC. | $9.16 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191676 | CMS |
| ABBVIE INC. | $3.98 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191678 | CMS |
| ABBVIE INC. | $2.42 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191680 | CMS |
| ABBVIE INC. | $9.96 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191682 | CMS |
| ABBVIE INC. | $3.34 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191684 | CMS |
| ABBVIE INC. | $3.73 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191686 | CMS |
| ABBVIE INC. | $13.73 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191688 | CMS |
| ABBVIE INC. | $10.00 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191690 | CMS |
| ABBVIE INC. | $2.40 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191692 | CMS |
| ABBVIE INC. | $5.16 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191694 | CMS |
| Astellas Pharma US Inc | $24.83 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139268284 | CMS |
| Astellas Pharma US Inc | $29.71 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139328734 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.53 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105326734 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.06 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104280571 | CMS |
| Exact Sciences Corporation | $23.33 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114572202 | CMS |
| GlaxoSmithKline, LLC. | $17.10 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115739134 | CMS |
| GlaxoSmithKline, LLC. | $14.85 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116106696 | CMS |
| Lilly USA, LLC | $19.04 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135493904 | CMS |
| Lilly USA, LLC | $16.08 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135493902 | CMS |
| Novo Nordisk Inc | $18.04 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097830976 | CMS |
| Radius Health, Inc. | $20.79 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1090000228 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.30 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153496338 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.